BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 7612339)

  • 1. Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis, and after hysterectomy.
    Griffiths F; Convery B
    Br J Gen Pract; 1995 Jul; 45(396):355-8. PubMed ID: 7612339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
    Haskell SG
    J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy in postmenopausal women: utilization of health care resources by new users.
    Thorp JM; Gavin NI; Ohsfeldt RL
    Am J Obstet Gynecol; 2001 Aug; 185(2):318-26. PubMed ID: 11518885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.
    Schonberg MA; Wee CC
    J Womens Health (Larchmt); 2005; 14(6):507-14. PubMed ID: 16115005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's use of hormone replacement therapy for disease prevention; results of a community survey.
    Ballard K
    Br J Gen Pract; 2002 Oct; 52(483):835-7. PubMed ID: 12392126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
    Perrone G; Capri O; Borrello M; Galoppi P
    Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women's decisions about whether or not to take hormone replacement therapy: influence of social and medical factors.
    Griffiths F
    Br J Gen Pract; 1995 Sep; 45(398):477-80. PubMed ID: 7546871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy: a study of women's knowledge and attitudes.
    Sinclair HK; Bond CM; Taylor RJ
    Br J Gen Pract; 1993 Sep; 43(374):365-70. PubMed ID: 8251232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of hormone replacement therapy in Washington State: is prevention being put into practice?
    Saver BG; Taylor TR; Woods NF
    J Fam Pract; 1999 May; 48(5):364-71. PubMed ID: 10334613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports.
    Gambrell RD; Natrajan PK
    Climacteric; 2006 Jun; 9(3):224-33. PubMed ID: 16766436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permanent cessation of menses and postmenopausal hormone use in dialysis-dependent women: the HELP study.
    Kramer HM; Curhan GC; Singh A;
    Am J Kidney Dis; 2003 Mar; 41(3):643-50. PubMed ID: 12612988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density in relation to medical and lifestyle risk factors for osteoporosis in premenopausal, menopausal and postmenopausal women in general practice.
    McKnight A; Steele K; Mills K; Gilchrist C; Taggart H
    Br J Gen Pract; 1995 Jun; 45(395):317-20. PubMed ID: 7619589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. After the Women's Health Initiative: decision making and trust of women taking hormone therapy.
    Schonberg MA; Davis RB; Wee CC
    Womens Health Issues; 2005; 15(4):187-95. PubMed ID: 16051110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Climacteric: concept, consequence and care.
    Taechakraichana N; Jaisamrarn U; Panyakhamlerd K; Chaikittisilpa S; Limpaphayom KK
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S1-15. PubMed ID: 12188398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.